Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Medical Officer

Chief Financial Officer

Chief Executive Officer

Chief Legal Officer

Executive President

VP, Controller&Acct Principal

Chief Accounting Officer

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company also develops MM-110, an a3ÃƒÅ¸4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. The company is headquartered in New York, New York.

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-25	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-03-25	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2024-03-25	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2023-12-26	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2023-12-26	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-12-26	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-09-25	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-09-25	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2023-09-25	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-08-25	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-06-27	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-06-27	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-06-27	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2023-06-21	Premium	acquired	Premium	Premium	Premium	-
2023-06-21	Premium	acquired	Premium	Premium	Premium	-
2023-06-21	Premium	acquired	Premium	Premium	Premium	-
2023-06-21	Premium	acquired	Premium	Premium	Premium	-
2023-06-21	Premium	acquired	Premium	Premium	Premium	-
2023-04-13	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2023-03-14	Premium	acquired	Premium	Premium	Premium	Executive President
2023-03-14	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-03-14	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-03-14	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-03-14	Premium	acquired	Premium	Premium	Premium	VP, Controller&Acct Principal

MNMD - Mind Medicine Stock Price, Fair Value and News

Latest Insider Trading transactions for MNMD